A single procedure solves the patient's three major problems!
In the face of patients' health needs.
They were unhesitating and
Carrying all the risks.
Carrying patients on their backs.
They carried the patient on their backs and crossed the treacherous shoals of life.
Recently, Xuzhou First People's Hospital Cardiovascular Surgery Professor Xue Song team, for a combination of chronic obstructive pulmonary disease, cerebral infarction, complex heart disease patients, the successful implementation of the "ceiling" level surgery - ascending aortic replacement + coronary artery bypass grafting + tricuspid valvuloplasty "triple" operation +Tricuspid valvuloplasty" three-in-one" surgery, at the same time solved the three major problems, so that the patient regained his "heart" life.
Mr. Zhang (a pseudonym), a patient living in Anhui Province, is 69 years old, although not old, but many diseases, chronic obstructive pulmonary disease, heart disease, cerebral infarction, resulting in his need to take a variety of drugs year-round. In late April this year, Mr. Zhang due to recurrent cough, cough sputum, asthma for 2 years, aggravated for more than 10 days in the local treatment is not good, come to Xuzhou hospital admitted to the Department of Respiratory and Critical Care Medicine, after the treatment of the symptoms improved significantly, but Mr. Zhang face sadness.
Originally, in the hospital for further examination and multidisciplinary consultation found that Mr. Zhang cardiovascular system problems are more serious: heart valve disease, tricuspid valve severe closure insufficiency, cardiac insufficiency, atrial fibrillation, coronary atherosclerotic heart disease, the right coronary artery stenosis is obvious, the ascending aorta dilatation. What was even more disturbing to Mr. Zhang was that these problems, for which medication alone had little effect, needed to be resolved by three major surgical procedures.
With Mr. Zhang's current physical condition, the situation will get worse if he doesn't have surgery; choosing to have surgery is a huge risk. When Mr. Zhang and his family were indecisive and hesitant, a piece of good news gave them a piece of mind: Professor Xue Song, Director of Cardiovascular Surgery of Xuzhou First Hospital and Cardiovascular Surgery Department of Shanghai Renji Hospital, is an authoritative expert in cardiovascular surgery in China, with a wealth of surgical experience. Mr. Zhang decided to be transferred to the Cardiac Macrovascular Surgery Department to receive surgical treatment.
Since the patient has chosen to trust, as a doctor, he can only be prudent and take all the risks with his excellent skills in order to live up to his trust. Prof. Xue Song often warns young doctors in this way.In cardiovascular surgery, ascending aorta replacement, coronary artery bypass grafting and valve surgery are all difficult surgeries. Mr. Zhang had many underlying diseases and poor cardiopulmonary function, and the three surgeries were performed at the same time, which made the surgeries traumatic and risky, and imposed harsh technical requirements on the doctors, and also put forward higher requirements for anaesthesia, extracorporeal circulation, and post-operative intensive care.Prof. Xue Song led the team to combine with multidisciplinary teams from Cardiovascular Medicine, Respiratory and Critical Care Medicine, Anesthesiology, Critical Care Medicine, Intervention and Catheterization, Medical Imaging and other departments to conduct sufficient preoperative examination, assessment, consultation and discussion, and formulated a detailed surgical plan and contingency plan for the patient in an effort to minimize the risk.
May 11, 08:30 Surgery started on time.
Time passed by, and the operation was carried out in a tense and orderly manner.During the operation, it was found that the patient's ascending aorta was dilated, the endothelium had localized ulcer formation, the tricuspid valve annulus was enlarged, and the degree of localized atherosclerosis and calcification of the right coronary artery was much worse than what was expected before the operation.Prof. Xue Song led the team members, including the department's executive director Shan Jianggui, deputy chief physician Wang Ruan, and attending physician Chen Xinyu, to take the saphenous vein, establish extracorporeal circulation, coronary artery bypass grafting, resection of the dilated ascending aorta, artificial blood vessel replacement, implantation of the tricuspid valvuloplasty ring, warming up, and cardiac resuscitation. ......On the operating table, they are guided by shadowless lamps and headlamp beams, and even if they are walking on the "tip of the knife", they are still calm and at ease. Under the close cooperation of the anesthesiology department, operating room and other multidisciplinary teams, the operation was completed successfully and the patient's vital indicators were stable.
Mr. Zhang is now recovering well and will be discharged soon.
Since its establishment in October 2023, the Department of Cardiovascular Surgery of Xuzhou First Hospital, under the leadership of Professor Xue Song, Director of the Department, has successfully treated nearly 100 cases of aortic coarctation, ruptured abdominal aortic aneurysm, severe valvular disease in the elderly, complex coronary artery disease, as well as patients with severe cardiac macrovascular diseases who are combined with valvular disease, coronary artery disease, and multiorgan dysfunction at the same time. The team adheres to the concept of "minimally invasive treatment and rapid recovery", and has successfully carried out minimally invasive coronary artery bypass grafting, minimally invasive repair of atrial septal and ventricular septal defects in congenital heart disease, minimally invasive heart valve replacement and plasty, and other minimally invasive surgical techniques, and has made the majority of cardiovascular disease patients in Huaihai region have a good chance to get rid of the problem of cardiovascular disease at home. With superb surgical skills and noble medical ethics, the hospital enables patients with cardiovascular diseases in Huaihai region to get rid of their heart diseases and have their hearts renewed at home.
Introduction of experts
Xue Song
Director of Cardiovascular Surgery, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
Chief Physician, Doctoral Supervisor
National Committee Member of the Thoracic and Cardiovascular Surgery Branch of the Chinese Medical Association (CMA)
Chairman of the Cardiac Macrovascular Surgery Society of Shanghai Medical Association
Standing Committee Member of the Cardiovascular Surgery Branch of Chinese Physicians Association
Vice Chairman of the Cardiovascular Surgery Branch of Shanghai Physicians Association
Vice Chairman, Minimally Invasive Cardiovascular Surgery Branch, National Cardiovascular Disease Center Expert Committee
Standing Member of Vascular Surgery Committee of National Cardiovascular Disease Center Expert Committee
Member of International Society of Minimally Invasive Cardiothoracic Surgery
Member of Asia-Pacific Society of Thoracic and Cardiac Surgery
Executive Director of the Surgery Branch of the Chinese Society of Ethnomedicine
Executive Member and Deputy Secretary General of Cardiovascular Surgery Technology and Engineering Society of China Pharmaceutical and Biotechnology Association.
Vice Chairman of the Cardiac Regeneration Group of the Chinese Medical Association's Tissue Repair and Regeneration Branch
Vice Chairman, Cardiovascular Surgery Group, Taiwan-Hainan Medical Development Committee, Cross-Strait Medical and Health Exchange Association.
Standing member of the Interventional Heart Valve Disease Technical Committee of the Asian Association of Heart Valve Disease (AAHVD), China Branch.
Awarded "Top Ten Doctors" in Shanghai.
Awarded the title of "Shanghai Craftsman" in 2022.
He has extensive experience in the field of coronary heart disease, large vessel disease, heart valve disease, congenital heart disease and surgical treatment of cardiac arrhythmia.
He specializes in non-stop coronary artery bypass grafting surgery, aortic coarctation and aortic aneurysm surgery, minimally invasive heart valve surgery with thoracoscopic assistance, complex congenital heart disease surgery and transcatheter aortic valve replacement.
In the Shanghai area, we are the first to successfully carry out "minimally invasive small-incision multi-vessel coronary artery bypass grafting", "four-valve heart valve replacement + giant ventricular septal defect repair", "triple bifurcation stenting of the aortic arch for the treatment of aortic coarctation ""Double valve replacement under acupuncture anesthesia" "Non-stop coronary artery bypass grafting under acupuncture anesthesia" as well as a variety of minimally invasive small incision cardiovascular surgery and other new technologies. In China, he was the first to carry out interventional therapy for various cardiovascular diseases.
He was awarded the Second Prize of Shanghai Medical Science and Technology in 2021.
He is the editorial board member of Chinese Journal of Thoracic and Cardiovascular Surgery, Innovations, Chinese Journal of Experimental Surgery, Chinese Journal of Surgical Abstracts, International Journal of Cardiovascular Disease, Chinese Journal of Cardiovascular Disease, etc. He is also the expert of peer review for the Chinese Journal of Medical Sciences, and has published more than 100 papers in domestic and foreign core journals, with more than 70 papers indexed in the SCI; he is also the author of the planned textbook "Surgery" by the Higher Education Press.
He is the deputy editor of the planning textbook "Surgery" of the Higher Education Press, and participated in the writing of the monographs "Lan Xijun Cardiovascular Surgery", "Cardiovascular Anesthesiology", "Adult Cardiac Surgery", and so on.
He has undertaken a number of national, provincial and ministerial level projects, including the National Natural Science Foundation of China, the sub-projects of the National 973 Project, the National Science and Technology Support Program, the key projects of Shanghai Municipal Science and Technology Commission, the key projects of Shanghai Municipal Bureau of Health, Pudong New Area, and the international cooperation projects. His main research interests include basic and clinical research on coronary heart disease and aortic coarctation.
He has been awarded the China Medical Science and Technology Award, Shanghai Science and Technology Progress Award, Shanghai Medical Science and Technology Award and other awards.
